A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/1994
11/30/1994	EP0626383A1 Palan'amine: a pharmacologically active compound from a sponge
11/30/1994	EP0626178A1 Use of inhibitors of HIV-protease for the treatment of tumorous diseases
11/30/1994	EP0625990A1 Glycoprotein complexes and glycoproteins
11/30/1994	EP0625983A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
11/30/1994	EP0526488B1 Benzylphosphonic acid tyrosine kinase inhibitors
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	CN1095724A Novel peptides the preparation and use thereof
11/30/1994	CN1095714A Phthalazinone derivatives
11/30/1994	CN1095589A Method and pharmaceutical preparations for reducing the activity of cells
11/30/1994	CN1026789C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
11/29/1994	US5369108 Potent inducers of terminal differentiation and methods of use thereof
11/29/1994	US5369101 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
11/29/1994	US5369096 Glycolipid derivatives
11/29/1994	US5369094 Polypeptide bombesin antagonists
11/29/1994	CA2124402A1 Use of o-esters of l-carnitine for producing pharmaceutical compositions for the treatment of dermatoses
11/29/1994	CA1333285C Morpholinoethylester of mycophenolic acid and derivatives thereof
11/29/1994	CA1333265C Coupling agents for radiolabeling proteins
11/24/1994	WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/24/1994	WO1994026910A1 Immunotoxins comprising gelonin and an antibody
11/24/1994	WO1994026892A1 Bmp-11 compositions
11/24/1994	WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	WO1994026876A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
11/24/1994	WO1994026875A1 New macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
11/24/1994	WO1994026730A2 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/24/1994	WO1994026723A2 ras FARNESYL TRANSFERASE INHIBITORS
11/24/1994	WO1994026707A1 Vitamin d amide derivatives
11/24/1994	WO1994026314A1 Compounds for cancer imaging and therapy
11/24/1994	WO1994026311A1 Anthracycline conjugates, their preparation and their use as antitumor agents
11/24/1994	WO1994026300A1 Insulin-like growth factor ii as antitumour agent
11/24/1994	WO1994026298A1 Methods for treating muscle diseases and disorders
11/24/1994	WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
11/24/1994	WO1994026284A1 Use of modified tall-104 cells to treat cancer and viral diseases
11/24/1994	WO1994026281A1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
11/24/1994	WO1994026278A1 Aurintricarboxylic acid fractions and analogues with anti-angiogenic activity and methods of use
11/24/1994	WO1994026277A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	WO1994026269A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
11/24/1994	WO1994026268A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994	WO1994026250A1 Method for treating neurological disorders
11/24/1994	WO1994019466A3 A novel family of anti-carcinoembryonic antigen chimeric antibodies
11/24/1994	CA2162990A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	CA2162853A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
11/24/1994	CA2162594A1 Insulin-like growth factor ii as antitumour agent
11/24/1994	CA2162556A1 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/24/1994	CA2162272A1 Vitamin d amide derivatives
11/24/1994	CA2161978A1 Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton
11/24/1994	CA2161777A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994	CA2160786A1 Ras farnesyl transferase inhibitors
11/24/1994	CA2139503A1 Compounds for cancer imaging and therapy
11/23/1994	EP0625523A1 Cis-oxalato(trans-L-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same
11/23/1994	EP0625517A1 Taxane having antitumor activity
11/23/1994	EP0625204A1 Hepatitis therapeutics
11/23/1994	EP0625200A1 Biosynthetic binding protein for cancer marker
11/23/1994	EP0625160A1 Leukinferon preparation
11/23/1994	EP0625148A1 Novel baccatine iii and 10-deacetyl baccatine iii derivatives, their preparation, and pharmaceutical compositions containing same
11/23/1994	EP0625051A1 Hepatic growth factor receptor
11/23/1994	EP0625045A1 Methods of treating inflammatory dermatoses
11/23/1994	EP0531461B1 Biologically active peptides containing d-2-alkyltryptophan
11/23/1994	EP0522013B1 Novel vitamin d analogues
11/23/1994	EP0464101B1 Improvements relating to the radio-labelling of proteins
11/23/1994	CN1095416A Hispidospermidin
11/23/1994	CN1095377A 7-halo- and 7beta, 8beta-methano-taxols, antineoplastic use and pharmaceutical compositions containing them
11/23/1994	CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/22/1994	US5367059 Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5366966 Compound UCE6
11/22/1994	US5366890 Alkaloids from cultures
11/22/1994	CA1333124C Antioxidant compositions and methods
11/18/1994	CA2123523A1 Use of compositions for combating tumour diseases
11/17/1994	EP0624645A1 Human chondromodulin-I protein
11/17/1994	EP0624590A1 N-acylated staurosporine derivatives, process and intermediates for their preparation and their use as medicaments
11/17/1994	EP0624586A1 Substituted pyrroles
11/17/1994	EP0624377A2 Lysosomal enzyme-cleavable antitumor drug conjugates
11/17/1994	EP0624196A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly.
11/17/1994	EP0624193A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins
11/17/1994	EP0624164A1 Peptides with organo-protective activity, process for their preparation and their use in the therapy
11/17/1994	EP0624096A1 Taxol as a radiation sensitizer
11/16/1994	CN1095070A Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/15/1994	US5364868 Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them
11/15/1994	US5364860 Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions
11/15/1994	US5364652 Potato starch treated with heat and hydrochloric acid and hydrolyzed with amylase and glucoamylase; dietetics; fibers; foods
11/13/1994	CA2123261A1 Urethanes and ureas that induce cytokine production
11/12/1994	CA2122937A1 Human chondromodulin-i protein
11/11/1994	CA2121567A1 Substituted pyrroles
11/10/1994	WO1994025627A1 Methods of treating and detecting cancer using viruses
11/10/1994	WO1994025626A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025588A2 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
11/10/1994	WO1994025477A2 Novel peptide nucleic acids
11/10/1994	WO1994025471A1 Phosphoramidates useful as antitumor agents
11/10/1994	WO1994025466A1 Water soluble derivatives of camptothecin and their use as antitumor agents
11/10/1994	WO1994025449A1 Oxidation products of cephalomannine
11/10/1994	WO1994025435A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
11/10/1994	WO1994025434A1 Peptidyl derivatives as metalloproteinase inhibitors
11/10/1994	WO1994025429A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/10/1994	WO1994025066A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/10/1994	WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025043A1 Peptides and compounds that bind to elam-1
11/10/1994	WO1994025016A1 Novel medical use for gaba agonists

1 ... 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 ... 2211